CTOs on the Move

Stratatech Corporation

www.stratatechcorp.com

 
Stratatech Corporation is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Stratatech Corporation raised $26M on 10/16/2018

Similar Companies

Avance Care

Avance Care is a primary care provider with locations in Charlotte and Raleigh Durham. They offer same day/next day appointments for pediatrics, teens, and adults, and provide comprehensive care for physical, mental, and emotional health.

Oakland Community Health Network

OCHN has a long-standing history of promoting independence, choice, and community inclusion for adults and children with intellectual / developmental disabilities, mental health concerns, and substance use disorders. Its mission to “inspire hope, empower people, and strengthen communities” reflects an unyielding belief in a "Valuable System for Valued People." Programs and supports provided by OCHN`s service network are available at www.oaklandchn.org. Most people who receive services through Oakland County`s public mental health system, which is managed by OCHN, have Medicaid insurance coverage.

PharmCentre

PharmCentre is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PHS

PHS is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alector

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.